Release Date: 28/02/14 12:17 Summary: Appendix 4E Preliminary Final Report Price Sensitive: Yes Download Document 158.57KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%